Status:
UNKNOWN
A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode
Lead Sponsor:
OrSense, Ltd.
Conditions:
Anemia
Eligibility:
All Genders
18-95 years
Brief Summary
The purpose of the study is to define the precision, accuracy and variability of the NBM-200 system in non invasive blood Hemoglobin (Hb) measurements relative to the laboratory blood analyzer by comp...
Detailed Description
Each subject will be placed in a comfortable position in a temperature regulated room. Participants will have two consecutive non invasive (NBM) measurements taken which involves inserting the thumb i...
Eligibility Criteria
Inclusion
- Aged 18 years and over
- Healthy volunteers
- Anemia patients
Exclusion
- Participants under the age of 18 years
- Patients with significant deformity, degenerative changes or oedema of the thumb or index fingers
- Patients with localized infection, ulceration or skin breaks involving the fingers
- Patients with vascular disease or Raynaud's phenomenon affecting the fingers
- Participants who are unable to give informed written consent
- Pregnancy
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2013
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01917487
Start Date
November 1 2011
End Date
November 1 2013
Last Update
September 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chaim Sheba Medical Center at Tel Hashomer
Ramat Gan, Israel, Israel, 52621